ClinicalTrials.Veeva

Menu

Anticholinergics for Cervical Edema in Labor (ACCEL)

The University of Texas System (UT) logo

The University of Texas System (UT)

Status and phase

Not yet enrolling
Phase 3
Phase 2

Conditions

Labor Dystocia

Treatments

Drug: Treatment with Diphenhydramine
Combination Product: Usual Care

Study type

Interventional

Funder types

Other

Identifiers

NCT06702670
HSC-MS-24-0841

Details and patient eligibility

About

The purpose of this study is to is to determine the clinical effectiveness of a single dose of intravenous (IV) medication for the prevention of labor arrest and cesarean delivery in primiparous women undergoing trial of labor.

Enrollment

200 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primiparous

  • Viable single intrauterine pregnancy

    -≥ 34 weeks of gestation

  • Ruptured membranes

  • Category I tracing at time of inclusion

  • Active phase of labor (>=6 cm of cervix dilation)

Exclusion criteria

  • Category II or III tracing
  • Allergy to the study medication (IV Diphenhydramine)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

Treatment with Diphenhydramine
Experimental group
Treatment:
Combination Product: Usual Care
Drug: Treatment with Diphenhydramine
Usual Care
Active Comparator group
Treatment:
Combination Product: Usual Care

Trial contacts and locations

1

Loading...

Central trial contact

Samantha Antonioli, MD; Aaron Roberts

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems